10 New Articles
Utility of microRNAs for the Diagnosis and Prognosis of Patients with Solid Tumors
Greg M. Arndt, Ph.D. Drug Discovery Manager, Children’s Cancer Institute Australia Mitch Raponi, Ph.D. Principal Research Scientist, Centocor Research and Development
Translational Medicine Perspectives in Drug Discovery and Development-PART VI: New Environment, New Challenges, New Solutions
Salvatore Alesci, Ph.D., Robin Fears Ph.D., Charles Gombar Ph.D., Charles Dormer, & Roy Baranello Giora Z Feuerstein MD, MSc, FAHA AVP and Head, Discovery Translational Medicine and TMRC, Scotland Wyeth Research, PA
Fluorescence Imaging Methods for Monitoring GPCR/G-protein Signaling in Single Live Cells
Tian Jin, Ph.D. Sr. Investigator, Chief, Chemotaxis Signal Section, LIG, NIAID, NIH
High-Content Analysis in Predictive Pharmacology and Toxicology
Jinghai James Xu, Ph.D., Director of Automated Biotechnology, Merck & Co., Inc.
Opportunities and Challenges of Biomarker Assays in Drug Development
View Full Article List
Francois Legay, Ph.D., Global Head of Marker Localization and Assay, Novartis, Inc.
Webcast Archive
The Next Frontier of Analytical SFC -- Embracing the Challenges of GMP Regulation
Sep 30, 2009 2:00 PM EST
Transferring Methods from Conventional HPLC to Fast Liquid Chromatography: A Practical Perspective Using Narrow-Bore Columns with Sub-Particles
Jan 22, 2009 12:00 AM EST
High-Throughput Optical Label-Free in Drug Discovery: From Biomolecular Interactions to Cellular Phenotypes
View More Webcasts on Demand
Jan 21, 2009 12:00 AM EST
